Recent Advances in Parkinson's Disease: Progress in Brain Research, cartea 252
Anders Bjorklund, Angela Cenci-Nilssonen Limba Engleză Hardback – 2 apr 2020
- Covers all key aspects of current research on Parkinson´s disease
- Includes topics that range from basic studies on disease models and pathogenic pathways (e.g., protein misfolding, immune and glial mechanisms) to clinical studies on disease features, microbiome, pathophysiology and therapeutic approaches
- Presents articles authored by world leaders in their respective fields
Din seria Progress in Brain Research
- 60% Preț: 509.60 lei
- 39% Preț: 1230.29 lei
- 9% Preț: 1232.44 lei
- 9% Preț: 1232.44 lei
- 5% Preț: 1281.30 lei
- 9% Preț: 1226.58 lei
- 5% Preț: 1281.42 lei
- 9% Preț: 1229.83 lei
- 9% Preț: 1232.44 lei
- 9% Preț: 1226.78 lei
- 32% Preț: 1228.99 lei
- 32% Preț: 1233.29 lei
- 29% Preț: 1283.57 lei
- 29% Preț: 1215.87 lei
- 32% Preț: 1154.95 lei
- 9% Preț: 1154.27 lei
- 9% Preț: 1151.54 lei
- 9% Preț: 1164.52 lei
- 9% Preț: 1160.07 lei
- 5% Preț: 2015.67 lei
- 5% Preț: 1207.95 lei
- 32% Preț: 1161.07 lei
- 32% Preț: 1157.18 lei
- 5% Preț: 2028.09 lei
- 9% Preț: 1155.98 lei
- 9% Preț: 1164.43 lei
- 9% Preț: 1164.43 lei
- 9% Preț: 1158.65 lei
- 9% Preț: 1164.50 lei
- 9% Preț: 1149.16 lei
- 9% Preț: 1159.43 lei
- 5% Preț: 1214.52 lei
- 9% Preț: 1153.55 lei
- 9% Preț: 1156.91 lei
- 9% Preț: 1156.05 lei
- 9% Preț: 1159.50 lei
- 9% Preț: 1156.91 lei
- 5% Preț: 1205.96 lei
- 9% Preț: 1161.24 lei
- 41% Preț: 1084.00 lei
- 9% Preț: 1221.36 lei
- 29% Preț: 1212.66 lei
Preț: 1169.16 lei
Preț vechi: 1713.11 lei
-32% Nou
Puncte Express: 1754
Preț estimativ în valută:
223.75€ • 233.10$ • 186.04£
223.75€ • 233.10$ • 186.04£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780444642608
ISBN-10: 0444642609
Pagini: 574
Dimensiuni: 191 x 235 mm
Greutate: 1.2 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Brain Research
ISBN-10: 0444642609
Pagini: 574
Dimensiuni: 191 x 235 mm
Greutate: 1.2 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Brain Research
Public țintă
Basic and clinical researchers in the field of neurodegeneration, proteinopathies and Parkinson´s disease.Cuprins
What we can learn from iPSC-derived cellular models of Parkinson’s disease?
Maria Claudia Caiazza, Charmaine Lang and Richard Wade-Martins
2. Animal models for preclinical Parkinson’s research: An update and critical appraisal
M. Angela Cenci and Anders Björklund
3. Selective neuronal vulnerability in Parkinson’s disease
Patricia Gonzalez-Rodriguez, Enrico Zampese and D. James Surmeier
4. Mechanisms of alpha-synuclein toxicity: An update and outlook
Inês Caldeira Brás, Mary Xylaki and Tiago Fleming Outeiro
5. The role of glia in Parkinson’s disease: Emerging concepts and therapeutic applications
Katarzyna Z. Kuter, M. Angela Cenci and Anna R. Carta
6. Innate and adaptive immune responses in Parkinson's disease
Aubrey M. Schonhoff, Gregory P. Williams, Zachary D. Wallen, David G. Standaert and Ashley S. Harms
7. Pathways of protein synthesis and degradation in PD pathogenesis
Rebekah G. Langston and Mark R. Cookson
8. Endosomal sorting pathways in the pathogenesis of Parkinson’s disease
Lindsey A. Cunningham and Darren J. Moore
9. New players in basal ganglia dysfunction in Parkinson's disease
Sara Meoni, Rubens Gisbert Cury and Elena Moro
10. Prodromal PD: A new nosological entity
Eva Schaeffer, Ronald B. Postuma and Daniela Berg
11. The gut microbiome in Parkinson’s disease: A culprit or a bystander?
Ali Keshavarzian, Phillip Engen, Salvatore Bonvegna and Roberto Cilia
12. Novel approaches to counter protein aggregation pathology in Parkinson's disease
Simon R.W. Stott, Richard K. Wyse and Patrik Brundin
13. Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience
Tom Foltynie and Dilan Athauda
14. Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease
Per Petersson, Andre
Maria Claudia Caiazza, Charmaine Lang and Richard Wade-Martins
2. Animal models for preclinical Parkinson’s research: An update and critical appraisal
M. Angela Cenci and Anders Björklund
3. Selective neuronal vulnerability in Parkinson’s disease
Patricia Gonzalez-Rodriguez, Enrico Zampese and D. James Surmeier
4. Mechanisms of alpha-synuclein toxicity: An update and outlook
Inês Caldeira Brás, Mary Xylaki and Tiago Fleming Outeiro
5. The role of glia in Parkinson’s disease: Emerging concepts and therapeutic applications
Katarzyna Z. Kuter, M. Angela Cenci and Anna R. Carta
6. Innate and adaptive immune responses in Parkinson's disease
Aubrey M. Schonhoff, Gregory P. Williams, Zachary D. Wallen, David G. Standaert and Ashley S. Harms
7. Pathways of protein synthesis and degradation in PD pathogenesis
Rebekah G. Langston and Mark R. Cookson
8. Endosomal sorting pathways in the pathogenesis of Parkinson’s disease
Lindsey A. Cunningham and Darren J. Moore
9. New players in basal ganglia dysfunction in Parkinson's disease
Sara Meoni, Rubens Gisbert Cury and Elena Moro
10. Prodromal PD: A new nosological entity
Eva Schaeffer, Ronald B. Postuma and Daniela Berg
11. The gut microbiome in Parkinson’s disease: A culprit or a bystander?
Ali Keshavarzian, Phillip Engen, Salvatore Bonvegna and Roberto Cilia
12. Novel approaches to counter protein aggregation pathology in Parkinson's disease
Simon R.W. Stott, Richard K. Wyse and Patrik Brundin
13. Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience
Tom Foltynie and Dilan Athauda
14. Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease
Per Petersson, Andre